trial
as of 2026-07-01Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia
NCTId NCT02001103
at a glance
Phase 3 · Unknown
Enrollment 120 (estimated)
Sponsored by National Taiwan University Hospital
Primary completion 2016-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Unknown
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2014-01
Primary completion
2016-07
Eligibility
ALL · 18 Years · 45 Years
Interventions & indications
Drugs
Sponsors
National Taiwan University HospitalLead Sponsor
Investigators
1
Chen-Chung Liu, MD, PhDPrincipal Investigator
Sites
1 total
Taipei, Taiwan
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
120
Phase
PHASE3
Primary Completion Date
2016-07
Status
UNKNOWN
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator
person